Suzhou Fushilai Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 96.29 million compared to CNY 156.49 million a year ago. Revenue was CNY 96.29 million compared to CNY 156.49 million a year ago.

Net income was CNY 5.79 million compared to CNY 51.61 million a year ago. Basic earnings per share from continuing operations was CNY 0.0631 compared to CNY 0.563 a year ago. Diluted earnings per share from continuing operations was CNY 0.0631 compared to CNY 0.563 a year ago.